NZ513087A - Bactericidal/permability -increasing protein (BPI) for treating chronic heart disease - Google Patents
Bactericidal/permability -increasing protein (BPI) for treating chronic heart diseaseInfo
- Publication number
- NZ513087A NZ513087A NZ513087A NZ51308700A NZ513087A NZ 513087 A NZ513087 A NZ 513087A NZ 513087 A NZ513087 A NZ 513087A NZ 51308700 A NZ51308700 A NZ 51308700A NZ 513087 A NZ513087 A NZ 513087A
- Authority
- NZ
- New Zealand
- Prior art keywords
- bpi
- bactericidal
- permability
- heart disease
- treating chronic
- Prior art date
Links
- 230000001684 chronic effect Effects 0.000 title abstract 3
- 208000019622 heart disease Diseases 0.000 title abstract 3
- 230000000844 anti-bacterial effect Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 208000020446 Cardiac disease Diseases 0.000 abstract 2
- 102000052586 bactericidal permeability increasing protein Human genes 0.000 abstract 2
- 108010032816 bactericidal permeability increasing protein Proteins 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 208000017667 Chronic Disease Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11673699P | 1999-01-22 | 1999-01-22 | |
| PCT/US2000/001515 WO2000043028A2 (en) | 1999-01-22 | 2000-01-21 | Method of treating chronic cardiac disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ513087A true NZ513087A (en) | 2003-02-28 |
Family
ID=22368911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ513087A NZ513087A (en) | 1999-01-22 | 2000-01-21 | Bactericidal/permability -increasing protein (BPI) for treating chronic heart disease |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6509317B1 (https=) |
| EP (1) | EP1143996B1 (https=) |
| JP (2) | JP2002535282A (https=) |
| CN (1) | CN1353614A (https=) |
| AT (1) | ATE239492T1 (https=) |
| AU (1) | AU778001B2 (https=) |
| CA (1) | CA2359681A1 (https=) |
| DE (1) | DE60002552T2 (https=) |
| MX (1) | MXPA01007031A (https=) |
| NZ (1) | NZ513087A (https=) |
| WO (1) | WO2000043028A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004517865A (ja) | 2000-12-01 | 2004-06-17 | ゾーマ テクノロジー リミテッド | Ｂｐｉタンパク質産物またはｂｐｉインヒビターを使用する、周皮細胞増殖の調節 |
| US20110002893A1 (en) * | 2008-11-03 | 2011-01-06 | Ut-Battelle, Llc | Diagnosis and treatment of congenital heart defects using nell1 |
| US9974759B2 (en) * | 2013-05-31 | 2018-05-22 | Indiana University Research And Technology Corporation | Beta 2 adrenoceptor antagonists for treating orthostatic hypotension |
| GB201319621D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Antimicrobial agents and their use in therapy |
| GB201319620D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Immunosuppressive agents and their use in therapy |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5643875A (en) | 1994-01-24 | 1997-07-01 | Friedmann; Nadav | Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
| US5578568A (en) * | 1994-04-22 | 1996-11-26 | Xoma Corporation | Method of treating conditions associated with intestinal ischemia/reperfusion |
| US5646114A (en) * | 1994-07-11 | 1997-07-08 | Xoma Corporation | Anti-protozoan methods |
| CN1236320A (zh) * | 1996-05-10 | 1999-11-24 | 爱克斯欧玛公司 | 杀菌的/增强通透性的蛋白质产物用于人脑膜炎球菌血症的治疗用途 |
-
2000
- 2000-01-21 DE DE60002552T patent/DE60002552T2/de not_active Expired - Fee Related
- 2000-01-21 CN CN00805115A patent/CN1353614A/zh active Pending
- 2000-01-21 MX MXPA01007031A patent/MXPA01007031A/es not_active IP Right Cessation
- 2000-01-21 CA CA002359681A patent/CA2359681A1/en not_active Abandoned
- 2000-01-21 JP JP2000594481A patent/JP2002535282A/ja active Pending
- 2000-01-21 EP EP00905696A patent/EP1143996B1/en not_active Expired - Lifetime
- 2000-01-21 WO PCT/US2000/001515 patent/WO2000043028A2/en not_active Ceased
- 2000-01-21 AU AU27341/00A patent/AU778001B2/en not_active Ceased
- 2000-01-21 NZ NZ513087A patent/NZ513087A/xx unknown
- 2000-01-21 US US09/488,979 patent/US6509317B1/en not_active Expired - Fee Related
- 2000-01-21 AT AT00905696T patent/ATE239492T1/de not_active IP Right Cessation
-
2003
- 2003-01-14 US US10/342,169 patent/US7045501B2/en not_active Expired - Fee Related
-
2006
- 2006-04-05 US US11/398,989 patent/US20060171937A1/en not_active Abandoned
-
2007
- 2007-01-19 JP JP2007010878A patent/JP2007126479A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000043028A9 (en) | 2001-09-20 |
| CA2359681A1 (en) | 2000-07-27 |
| US20030216312A1 (en) | 2003-11-20 |
| DE60002552T2 (de) | 2004-02-26 |
| US20060171937A1 (en) | 2006-08-03 |
| ATE239492T1 (de) | 2003-05-15 |
| JP2007126479A (ja) | 2007-05-24 |
| EP1143996A4 (de) | 2002-04-24 |
| JP2002535282A (ja) | 2002-10-22 |
| DE60002552D1 (de) | 2003-06-12 |
| AU778001B2 (en) | 2004-11-11 |
| AU2734100A (en) | 2000-08-07 |
| WO2000043028A2 (en) | 2000-07-27 |
| WO2000043028A3 (en) | 2000-11-30 |
| US6509317B1 (en) | 2003-01-21 |
| CN1353614A (zh) | 2002-06-12 |
| EP1143996A2 (en) | 2001-10-17 |
| US7045501B2 (en) | 2006-05-16 |
| MXPA01007031A (es) | 2004-08-12 |
| EP1143996B1 (en) | 2003-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9714363A (pt) | Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas | |
| PT913156E (pt) | Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia | |
| CY1109191T1 (el) | Μια νεα χρηση της δεφεριπρονης | |
| EA200501023A1 (ru) | Терапевтические составы для лечения болезней, связанных с наличием бета-амилоида | |
| EP1064000A4 (en) | VITAMIN D AND ITS ANALOGS FOR THE TREATMENT OF TUMORS AND OTHER HYPERPROLIFERATION DISORDERS | |
| ATE373679T1 (de) | Antimikrobiell wirksames oder endotoxin neutralisierendes polypeptid | |
| EA200400825A1 (ru) | Способы замедления старения, а также лечения и профилактики заболеваний, связанных со старением | |
| WO2003092617A3 (en) | Combinations for the treatment of inflammatory skin disorders | |
| ES2849566T3 (es) | Composiciones farmacéuticas y usos dirigidos a trastornos de almacenamiento lisosomal | |
| WO2000040273A3 (en) | Treatment of viral diseases using an interferon omega expressing polynucleotide | |
| WO2003034996B1 (en) | Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment | |
| DE50110262D1 (de) | Verwendung von bradycardica bei der behandlung von mit hypertrophie einhergehenden myocarderkrankungen und neue arzneimittelkombinationen | |
| NZ513087A (en) | Bactericidal/permability -increasing protein (BPI) for treating chronic heart disease | |
| WO2003057162A3 (en) | Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases | |
| BR0312929A (pt) | Uso de um composto, e, métodos de tratamento, prevenção ou alìvio de uma doença, distúrbio ou condição de um corpo de animal vivo, e da degeneração macular relacionada com a idade de um corpo de animal vivo | |
| MXPA02009603A (es) | Terapias de dosis divididas con actividad de deterioro vascular. | |
| PT1235573E (pt) | Associacao de riluzole e de gabapentina e sua utilizacao como medicamento no tratamento das doencas motoneuronais | |
| EP4434583A3 (en) | Crystalline (r)-5-carbamoylpyridin-3-yl-2-methyl-4-(3-(trifluoromethoxy)benzyl) piperazine-1-carboxylate, compositions and methods of use thereof | |
| WO2000015783A3 (en) | ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO β1-ADRENOCEPTOR-SPECIFIC mRNA AND METHODS OF USE | |
| MC2203A1 (fr) | Medicament contre la cryptosporidiose | |
| DE997146T1 (de) | Medikament zur behandlung der diabetischen nierenkrankheit und zur verspätung der niereninsuffizienz | |
| WO2009069002A3 (en) | Low dose colony stimulating factors to treat amyloidosis | |
| WO2025265013A3 (en) | Rnai agents for inhibiting expression of huntingtin (htt), compositions thereof, and methods of use | |
| Ambrose | Treatment of the Lesser Ailments of Aging: Phosphodiesterase Type 5 Inhibitors | |
| IL110888A0 (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| ERR | Error or correction |
Free format text: THE OWNER HAS BEEN CORRECTED TO 844159, XOMA TECHNOLOGY LTD., 2910 SEVENTH STREET, BERKELEY, CA 94710, US; 857962, BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, 201 WEST 7TH STREET, AUSTIN, TEXAS 78701, US Effective date: 20140808 |